PHASE II/III BIOMARKER-DRIVEN MASTER PROTOCOL FOR PREVIOUSLY TREATED SQUAMOUS CELL LUNG CANCER. (LUNG-MAP) THIS SLIDE DECK CONTAINS AN OVERVIEW OF THE.
